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Eurycomanone is a cytotoxic ingredient found in Eurycoma longifolia Jack. 
Previous studies have noted its activity against many epithelial cell lines. In this 
study, eurycomanone had obvious cytotoxic effect on HeLa cells by methylene 
blue staining assays. After HeLa cells were treated with eurycomanone, typical 
morphological changes, including cytoplasm shrinkage and decrease of cell 
volume were observed by light microscope. Chromatin condensation and nuclear 
fragmentation could be observed by fluorescence microscope after staining with 
Hoechst 33258 nuclear staining. DNA fragmentation and apoptotic body 
formation that is characteristic of apoptosis could be determined after treated 
cells were assayed with TUNEL (terminal deoxynucleotidyl transferase mediated 
d-UTP nick end labeling). The externalization of phosphatidyl serine (PS) could 
be determined by flow cytometry analysis using Annexin-V/PI double staining. 
The result suggested that eurycomanone exerted antiproliferative activity on 
HeLa cells by inducing apoptosis.  




Eurikomanon adalah senyawa yang bersifat sitotoksik yang ditemukan 
dalam Eurycoma longifolia Jack. Kajian terdahulu telah melaporkan aktivitas 
sitotoksiknya terhadap beberapa turunan sel-sel kanker. Pada kajian ini, 
eurikomanon menunjukkan efek sitotoksik terhadap sel HeLa yang ditunjukkan 
dengan pengecatan metilen biru. Setelah perlakuan dengan eurikomanon, 
perubahan-perubahan morfologi yang khas seperti pengecutan sitoplasma dan 
pengecilan ukuran sel teramati dengan pengamatan mikroskop cahaya. 
Kondensasi kromatin dan fragmentasi inti teramati setelah pengecatan dengan 
Hoechst 33258. Fragmentasi DNA dan pembentukan jasad apoptotik                    
yang merupakan karakteristik apoptosis dapat teramati setelah sel yang               
diberi perlakuan eurikomanon dideteksi menggunakan TUNEL (terminal 
deoxynucleotidyl transferase mediated d-UTP nick end labeling). Eksternalisasi 
fosfatidil serin (PS) dapat teramati menggunakan analisis flowcytometri 
menggunakan pengecatan berganda Annexin V/PI. Hasil kajian menunjukkan 
bahwa eurikomanon mempunyai aktivitas antiproliferatif dengan menginduksi 
apoptosis. 
Kata kunci : eurikumanon, sitotoksik, apoptosis, HeLa 
 
Introduction 
Apoptosis is the process of 
programmed cell death through a tightly 
controlled program that plays important 
roles in many normal processes (Reed, 
2001). During apoptosis, the nucleus and 
cytoplasm condense to produce membrane-
bound apoptotic bodies that are 
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phagocytosed by macrophages or adjacent 
cells. Compounds that block or suppress the 
proliferation of tumor cells by inducing 
apoptosis are considered to have potential as 
anti tumor agents (Frankfurt and               
Krishan, 2003). 
Apoptosis is associated with a distinct 
set of biochemical and morphological 
changes involving the cytoplasm, nucleus 
and plasma membrane (Allen et al., 1997). 
Early in apoptosis, the cells round up, losing 
contact with their neighbors, and shrink. In 
the nucleus, chromatin condenses and 
aggregates into dense compact masses,              
and is fragmented internucleosomally by 
endonucleases (Lawen, 2003). The nucleus 
becomes convoluted and buds off into 
several fragments, which are encapsulated 
within the forming apoptotic bodies 
(Gewies, 2003; Kerr et al., 1994).                    
Under physiological conditions, certain 
modifications in the plasma membrane 
occur, which enable the recognition of 
apoptotic bodies by phagocytic cells (Savill 
and Fadok, 2000).  
Eurycomanone is one of promising 
compound to be developed as antitumor 
agent. The previous studies had noted its 
cytotoxicity against various cancer cell lines 
(Kardono et al., 1991; Kuo et al., 2004; 
Cheah and Azimahtol, 2004) and apoptosis 
had noted as the important mechanism 
involves in its cytotoxicity.  
Cervical carcinoma is one of the most 
common neoplastic diseases among women, 
with a combined worldwide incidence of 
almost half a million new cases annually, 
second ranking after breast cancer (Franco et 
al., 2003). Therefore, the development of 
chemotherapeutic/ chemopreventive agents 
against cervical carcinoma is very important 
to reduce the incidence and mortality of this 
disease. The main aim of this paper was to 
study the cytotoxic effect of eurycomanone 
on human cervical carcinoma (HeLa) cells 
and explore through morphological and 
biochemical observation whether the effect 




Plant materials  
E. longifolia roots were provided by Prof. 
Dr. Azimahtol Hawariah Lope Pihie (National 
University of Malaysia). 
 
Compound extraction  
Eurycomanone was extracted from the 
root of E. longifolia as previously described 
(Darise et al., 1982). The root of the plant was 
dried, ground and extracted with methanol. The 
methanolic extract was then concentrated to 
dryness. A suspension of the dry extract in water 
was separated with diethyl ether using separating 
funnel. The water fraction was then separated 
with n-buthanol saturated with water. The 
buthanol layer was then evaporated to dryness 
and the residue was subjected to column 
chromatography over silica gel using a mixture 
of ethyl acetate-ethanol-water (100:10:1) as the 
mobile phase. The isolated compound was 
confirmed as eurycomanone by comparing the 
NMR spectral data with published value 
(Kardono et al., 1991; Chan et al., 1986). 
 
Cell culture conditions 
All cell lines (CaOv-3, HeLa, HepG2, 
HM3KO, MCF-7, Vero and MDBK) were 
obtained from American Type Culture Collection 
(ATCC). The cell lines were maintained                    
in DMEM medium supplemented with 5 %                 
fetal bovine serum (FBS) and 1 % penicillin 
streptomycin. The cells were grown at 37  °C in 
humidified atmosphere of 5 %  CO2. 
 
Cell proliferation assay 
The antiproliferative effect of 
eurycomanone was evaluated by obtaining the 
IC50 values for the above mentioned cancer cell 
lines as previously described (Lin and Hwang, 
1991; Lee and Azimahtol, 2003). In the 
experiment, logarithmically growing HeLa cells 
were seeded at a density of 5.103 cells/well into    
96-well plates and allowed to adhere for 24 hrs              
at 37 °C. Then the seeding medium was discarded 
and replaced with fresh medium containing 
varying concentration of compound. The cells 
were maintained for 3 days and the 
antiproliferative activity of eurycomanone was 
determined using the methylene blue staining. 
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Glutaraldehyde was added to each well to a final 
concentration of 2.5 % (v/v). Following of                 
15 minutes incubation, the cells were washed with                     
0.15 M NaCl.  The cells were then stained with 
0,1 mL of 0.05 % methylene blue solution for               
15 minutes. The excess dye was washed out and               
0.2 mL of 0.33 M HCl was added into each well. 
The absorbance was read at 660 nm. 
 
Giemsa staining 
Giemsa staining was assayed according to 
the method previously described (Song and 
Zhang, 2006). The eurycomanone treated HeLa 
cells were tripsinized and washed twice with PBS 
using centrifugation. The cells were overlaid on 
the slides   and   allowed  to  dry  in   room 
temperature. Then the cells were fixed with                
100 % ethanol for 15 min and stained with 
Giemsa for 30 min. Following staining, the slides 
were washed with distilled water. After drying, 
the slides were observed under light microscope. 
 
Nuclear staining assay 
Staining with Hoechst 33258 was 
performed according to the method previously 
described (Hishikawa et al., 1999; Tee and 
Azimahtol, 2005). HeLa cells were seeded onto 
poly-L-lysin slide. After 24 hrs adherence the old 
medium was discarded and replaced with fresh 
medium containing eurycomanone (2 µg/mL). 
The treated cells were incubated for 24 and 72 hrs. 
Following incubation, the cells were washed with 
PBS and fixed with 4 % methanol free para 
formaldehyde for 30 minutes at 4 °C. The fixed 
cells were washed with PBS and stained with 
Hoechst 33258 (Sigma) at a final concentration of 




DNA fragmentation, that is characteristic 
of apoptotic cells, was examined by TdT-
mediated dUTP nick end labeling (TUNEL). 
HeLa cells were seeded onto a poly-L-lysine slide 
in a petri dish. After 24 hrs adherence, the cells 
were incubated without and with eurycomanone 
(2 µg/mL) for 24 and 72 hrs. At the end of the 
treatment, the cells were fixed with 4 % 
methanol free paraformaldehyde in PBS at 4 °C 
for 30 minutes and then washed with PBS for 
further analysis. The cells were stained with 
TUNEL assay kit Florescein (Promega) 
according to the manufacturer’s instruction. This 
assay specifically detects apoptotic cells when 
visualized through the fluorescent microscope. 
 
Flow cytometry analysis 
The externalization of PS in the apoptotic 
cells can be assessed by measuring the binding of 
FITC-conjugated annexin-V to cells and the 
number of apoptotic cell death could be 
measured by flow cytometer. In this study, the 
number of HeLa cell death induced by 
eurycomanone was analysed with flow 
cytometer (Dakocytomacion) using the 
APOPTESTTM-FITC according to manu-
facturer’s protocol. The treated and untreated 
HeLa cells were harvested and washed with cold 
PBS. An aliquot of 100 µL of 106/mL cell 
suspension was added with 1 µL Annexin-V 
FITC and 2.5 µL propidium iodide (250 µg/mL). 
After 10 minutes incubation on ice, the cells 
were measured immediately. 
 
Results and Discussions 
The ability of certain compound to 
suppress proliferation of tumor cells and            
induce tumor cell apoptosis is the  
important properties should have by an 
anticancer drug candidate (Frankfurt and 
Krishan, 2003). 
Eurycomanone (Fig. 1) significantly 
reduced the viability and proliferation of 
cancerous cells (CaOv-3, HeLa, HepG2, 
HM3KO and MCF-7) in comparison with 
control in a dose dependent manner (Fig. 2).  
The IC50 values of eurycomanone on 
cancerous cell lines were found less than            




Figure 1. Chemical structure of euryco-
manone. 
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potency of eurycomanone as antipro-
iferative agent since the IC50 is less than 20 
µg/mL (Wall et al., 1987). Eurycomanone 
also showed the ability to act as a 
cytoselective anticancer agent since 
eurycomanone was  relatively nontoxic 
towards non-cancerous MDBK and Vero 
cells. Previous research also showed the 
minimum effect of eurycomanone on non 
cancerous breast cells (MCF-10A) (Cheah 
and Azimahtol, 2004). The cytoselective 
properties of eurycomanone led to 
expectation that eurycomanone was 
potential to develop as anticancer agent. 
Since, the important problem in cancer 
treatment is non-selectivity of chemotherapy 
on normal cells. This problem limited the 
effect and responsible for many adverse 
effect of chemotherapy  (Kerr et al., 1994). 
 
Morphological observation by inverted 
microscope 
Under inverted microscope, cell shape 
and its changes can be observed clearly. As 
shown in Fig. 3a, cells in the control group 
showed regular polygonal and cell antennas  
were short and there were very few round 
cells. Cells treated with eurycomanone 
showed obvious morphological changes, 
including the loss of adhesion, rounding, and 
sporadical distribution (Fig. 3b-3c), and 
there was    clear concentration-dependent 
response, indicating the possibility of 
apoptosis occurrence. 
 
Morphological observation with Giemsa 
staining 
Giemsa staining can detect apoptotic 
cells (Song and Zhang, 2006). Apoptotic cells 
and apoptotic bodies will stain dark blue as 
the chromatin condensed, while healthy 
cells will stain brightly (Oka et al., 1997; 
Song and Zhang, 2006). Giemsa stain 
attaches itself to regions of DNA where 
there are high amounts of adenine-thymine 
bonding. As shown in Fig. (3e-3f), 
eurycomanone treated HeLa cells were 
stained dark blue, indicating the 
condensation of chromatin. The cells ize was 
also found to reduce. At  igher consentration 





Figure 2. Cytotoxic effects of eurycomanone on cell viability. Treatment of eurycomanone 
on cancerous cells (CaOv, HeLa, HepG2, HM3KO and MCF7) significantly 
reduced the number of viable cells. It was relatively nontoxic against non 
cancerous cells (MDBK, Vero). Results were represented as means ± SEM of at 
least 3 independent experiments. 
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Nuclear morphology observation 
Cells undergoing apoptosis display a 
profound destruction of the nucleus that 
results in the formation of nuclear blebs 
containing DNA. Staining of apoptotic cells 
with fluorescent DNA binding stain allows 
for easy detection of this phenomenon, 
because DNA-filled dye stain brightly, and are 
easily distinguished from intact nuclei 
(Dibartolomeis and Mone, 2003). The 
morphology of apoptotic cells including 
chromatin condensation and formation of 
apoptotic bodies could be determined after 
staining with Hoechst 33258. Hoechst 33258 
bind at specific site of double stranded DNA 
and display a green fluorescence. However, 
Hoecsht 33258 stain both of live cells and 
apoptotic cells. Live cells could be easily 
distinguished from apoptotic cells, because live 
cells will stain homogenously while apoptotic 
cells will stain brightly (Brown, 2003). 
Staining with Hoechst 33258 on 
eurycomanone treated HeLa cells for 24 hrs 
(Fig. 4b) showed intense fluorescence in the 
 
Figure 3. Morphological observation with light microscope on untreated HeLa cells          
(a), eurycomanone treated cells of 2 µg/mL (b) and 4 µg/mL (c); Giemsa staining 
of untreated HeLa cells (d), HeLa cells were treated with 2 µg/mL (e) and                     




Figure 4. Nuclear staining with Hoechst 33258 on untreated cells (a), HeLa cells were 
treated with 2 µg/mL eurycomanone for 24 hrs (b) and 72 hrs (c); TUNEL assay 
of untreated HeLa cells (d), HeLa cells treated with 2 µg/mL eurycomanone for 
24 hrs (e) and 72 hrs (f). 
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nucleus, thereby indicating chromatin 
condensation and fragmentation of the DNA 
in the nucleus. At 72 hrs after treatment, the 
florescence occurred more intensively and the 
formation of apoptotic bodies was detected 
(Fig. 4c), indicating the late stage of 
apoptosis. 
 
DNA fragmentation, biochemical charac-
teristic of apoptosis 
The DNA fragmentation of apoptotic 
cells generates 3’-OH DNA ends, which can 
be labeled with fluorescein-12-dUTP using 
the enzyme Terminal Deoxynucleotidyl 
Tranferase (TdT). The fluorescein-12-dUTP-
labeled DNA could be visualized                         
by fluorescence microscope. DNA 
fragmentation is the primary biochemical 
characteristics (Allen et al., 1997) which 
indicate an early event of apoptosis and it 
represents a point of no return from the 
path to cell death. This due to no more new 
cellular protein will be synthesized for cell 
survival. 
HeLa cells were treated with 
eurycomanone for 24 hrs (Fig. 4e) showed 
active apoptosis and the fragmented DNA 
were labeled with fluorescence 12 dUTP in 
the nuclei. At 72 hrs after treatment more 
intensive fluorescence were detected, thereby 
indicating more DNA fragmentation of 
treated cells. The formation of apoptotic 
bodies in these cells indicated the late stage of 
apoptosis (Fig. 4f). In HeLa cells treated with 
DMSO as negative control, no fluorescence 
was detected in the nuclei, due to the absence 
of fragmented DNA (Fig. 4d).  
 
Flow cytometry analysis 
In many cell types, the induction of 
apoptosis is associated with plasma 
membrane changes where PS is translocated 
from the inner layer of plasma membrane to 
the outer leaflet, a process which required 
for phagocytosis by macrophages (Savill and 
Fadok, 2000). The externalization of PS can 
be assessed by measuring the binding of 
FITC-conjugated annexin-V to cells by flow 
cytometry. The combination between 
annexin-V and DNA-binding flouresence 
dye (PI) can distinguish the apoptotic and 
necrotic cells, as the apoptotic cells exclude 
PI. A typical cytogram is shown where cells 
stained negative for both annexin-V and PI 
(PS−/PI−) were live cells. Annexin-V-
 
 
Figure 5. Flow cytometry analysis of HeLa cells. The increasing of the number of apoptotic 
cells were followed by the increasing of secondary necrotic cells number in 
eurycomanone treated HeLa cells, indicating the apoptotic cells with no 
phagocytic clear-up enter into secondary necrotic stage. 
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positive and PI-negative (PS+/PI−) stained 
cells undergo early stages of apoptosis where 
the plasma membrane were still intact and 
excluded PI. In late stages of apoptosis, 
dying cells can no longer exclude PI and 
displayed both annexinV-positive and PI-
positive (PS+/PI+). PI-positive and 
annexinV-negative (PS−/PI+) stained cells 
were necrotic cells. Our data confirms that 
eurycomanone was capable of inducing cell 
death in HeLa cells (Fig. 5). 
Flow cytometric analysis of euryco-
manone treated cells showed externalization 
of PS as assessed by annexin-V binding. PS is 
normally restricted to the inner-membrane 
leaflet, however dying cells expose these 
phospholipids as it is one of the key signals 
for phagocyte recognition (Fadok and 
Henson 2003). The concentration of 
eurycomanone used for treating the cells was 
2 µg/mL (IC50 values of eurycomanone 
detected for 3 days treatment were 2.13 ± 
0.09 µg/mL). As shown in Fig. 5,                      
the background level of apoptosis in              
HeLa cells were 15.51 ± 0.33 %                                       
and background level of necrosis were               
5.636 ± 0.17 %. After exposure with 
eurycomanone the level of apoptotic cells 
was increased  from 15.51 ± 0.33 % to 22.54 
± 2.19 %, 28.06 ± 0.89 % and 26.96 ± 0.49 % 
after exposure with eurycomanone for              
24, 48 and 72 hrs. The cells in the secondary 
necrosis stage were also found to increase 
from 5.54 ± 0.19 % to 9.78 ± 1.02 % at 
24hrs, 14.71 ± 0.85 % by 48hrs and                
25.72 ± 2.77 % after 72hrs treatment.           
There is no significant difference of 
apoptotic cells after 72 hrs treatment 
compared to 48 hrs while the secondary 
necrotic cells were significantly increased. 
These result suggested that treatment of 
eurycomanone on HeLa cells induced 
apoptosis and the apoptotic cells with no 
phagocyte surrounding them in the in vitro 
study then enter to secondary necrotic stage.  
Therefore, there were no more 
increasing of apoptotic level after 72 hrs 
since the apoptotic cells entered into 
secondary necrotic stage. 
 
Conclusions 
Eurycomanone is cytotoxic on HeLa 
cells by inducing apoptosis and less toxic on 
normal cells. This finding may suggest 
further investigation of eurycomanone as 
anticancer agent. 
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